Johnson & Johnson Gives AIDS Drug Rights To Charity For Vaginal Ring

Published: May 09, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Johnson & Johnson (JNJ) gave the rights to an experimental AIDS drug to a charity that’s testing the medicine in a vaginal ring to prevent HIV infection. J&J gave the global rights to develop and market dapivirine to the International Partnership for Microbicides, a Silver Spring, Maryland-based organization that works on developing HIV prevention tools for women, IPM said today in a statement.

Help employers find you! Check out all the jobs and post your resume.

Back to news